Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 11Gastrointestinal 4CNS 2Thoracic 1Plasma cell 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Multiple Myeloma 444Neoplasms, Plasma Cell 77Recurrence 62Lymphoma 52Lymphoma, Non-Hodgkin 48Leukemia 43Hodgkin Disease 43Leukemia, Myeloid, Acute 42Myelodysplastic Syndromes 37Leukemia, Lymphocytic, Chronic, B-Cell 35Precursor Cell Lymphoblastic Leukemia-Lymphoma 34Lymphoma, Mantle-Cell 29Lymphoma, Large B-Cell, Diffuse 29Lymphoma, Follicular 27Hematologic Neoplasms 24Burkitt Lymphoma 24Immunoglobulin Light-chain Amyloidosis 22Myeloproliferative Disorders 21Lymphoma, B-Cell, Marginal Zone 21Waldenstrom Macroglobulinemia 18Lymphoma, Large-Cell, Immunoblastic 18Neoplasms 17Lymphoma, T-Cell, Cutaneous 16Lymphoma, Large-Cell, Anaplastic 14Leukemia, Myelomonocytic, Chronic 14Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Sezary Syndrome 13Mycosis Fungoides 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 12Leukemia, Myeloid, Accelerated Phase 12

Interventions

resiquimod 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Chondrosarcoma × Plasma cell × Clear all
NCT00948961 2016-06-27

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Celldex Therapeutics

Phase 1/2 Completed
70 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicPlasma cellSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Esophageal Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡